Pfizer Inc PFE

$27.40 -0.14 (-0.51%)

Valuation

Market cap
156,176,000,000
Revenue TTM
$62,579,000,000
Net income TTM
$7,771,000,000
P/E (trailing)
9.03
P/E (forward)
9.05
Profit margin
12.42%
Debt to equity
0.70

Trading

Volume
38,319,600
Avg volume
34,049,391
Day's range
$27.35 – $28.11
Shares out
5,699,854,000
Stochastic %K
2%
Beta
0.31
Analysts
Hold
Price target
$30.56

Price

Company profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under...

Show more

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
212 733 2323
Website
https://www.pfizer.com
Address
66 Hudson Boulevard East, New York, United States

Latest news

Stocktwits

CrazyCajun7 Nov 22, 6:23 PM 0 replies
openclassaction2 Nov 22, 9:37 AM
$PFE the $44 million pfizer chantix settlement is pending approval, per open class actions. suit alleged chantix had an undisclosed nitrosamine impurity. claims closed, court decides next. pharma risk, priced in court
0 replies
ST_Tropez_Trading Nov 22, 8:36 AM
$SLS Ahh FFS – what are you, 15??? If I had a dollar for every '' cUrE fOr cAnCeR'' since the 1990s 😂 The WKHS was 150,000+ real, fungible trucks, and it happened. I don't think you understand life yet: THEY DO NOT WANT TO CURE CANCER!!! They don't want to stop crime either. CANCER is, more than likely, purposefully introduced into the population by governments – because ''tin foil hat me all you like'' – it controls populations, creates jobs, and it's strangely a relatively 'new' thing that was rare in humans before the 1980s. These days, it's near everybody. Go figure. You cure cancer and suddenly entire companies, lawyers, specialists and private hospitals are all going BUST – just so you can get rich off one little ticker? I don't think so, mate. Let that sink in. $JNJ $PFE $MRK $MRNA
5 replies
Sha_B_Ral Nov 22, 7:10 AM
$PFE You idiot. Hurry up~!!!! We want to be acquired by an American company. Not a French one.
0 replies
TooHot_toTouch Nov 22, 5:48 AM
$SLS Is it a 2 horse race or 3 ? $JNJ $MRK $PFE
1 replies
CrazyCajun7 Nov 22, 5:46 AM 0 replies
CrazyCajun7 Nov 22, 5:34 AM 0 replies
CrazyCajun7 Nov 22, 5:21 AM 0 replies